Sophie Fletcher

机构：The University of Sydney, Australian Nuclear Science and Technology Organisation, British Thoracic Society, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, NIHR Southampton Respiratory Biomedical Research Unit, NIHR Southampton Biomedical Research Centre, University of Southampton · ORCID：0000-0002-5633-905X

发表论文 125 篇 · 总被引 4552 次 · h-index 28

代表论文

• Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis (2022 · The Lancet · 被引 328)
• Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial (2022 · The Lancet Respiratory Medicine · 被引 281)
• Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study (2022 · The Lancet Respiratory Medicine · 被引 215)
• Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2023 · The Lancet · 被引 132)
• Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease (2024 · Nature Immunology · 被引 98)
• Spatially resolved deconvolution of the fibrotic niche in lung fibrosis (2022 · Cell Reports · 被引 52)